ITGAV

Chr 2AR

integrin subunit alpha V

Also known as: CD51, IDNDC, MSK8, VNRA, VTNR

The product of this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha subunit and a beta subunit that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha V subunit. This subunit associates with beta 1, beta 3, beta 5, beta 6 and beta 8 subunits. The heterodimer consisting of alpha V and beta 3 subunits is also known as the vitronectin receptor. This integrin may regulate angiogenesis and cancer progression. Alternative splicing results in multiple transcript variants. Note that the integrin alpha 5 and integrin alpha V subunits are encoded by distinct genes. [provided by RefSeq, Oct 2015]

OMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 0.441 OMIM phenotype
Clinical SummaryITGAV
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.30) despite low pLI — interpret in context.
📋
ClinVar Variants
6 unique Pathogenic / Likely Pathogenic· 140 VUS of 205 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.44LOEUF
pLI 0.000
Z-score 5.13
OE 0.30 (0.210.44)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
0.89Z-score
OE missense 0.89 (0.830.96)
505 obs / 564.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.30 (0.210.44)
00.351.4
Missense OE?0.89 (0.830.96)
00.61.4
Synonymous OE?0.96
01.21.6
LoF obs/exp: 19 / 62.9Missense obs/exp: 505 / 564.3Syn Z: 0.44

This gene — mechanism propensity

DN
0.6939th %ile
GOF
0.6735th %ile
LOF
0.3164th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative, gain-of-function and loss-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median
LOF67% of P/LP variants are LoF · LOEUF 0.44

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

205 submitted variants in ClinVar

Classification Summary

Pathogenic3
Likely Pathogenic3
VUS140
Likely Benign14
Benign5
3
Pathogenic
3
Likely Pathogenic
140
VUS
14
Likely Benign
5
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
2
0
0
3
Likely Pathogenic
3
0
0
0
3
VUS
0
140
0
0
140
Likely Benign
0
4
5
5
14
Benign
0
0
1
4
5
Total414669165

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

26 pathogenic / likely-pathogenic (of 30) ClinVar copy-number / structural variants overlap ITGAV — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ITGAV · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →